Trane Technologies PLC

This management proposal asks shareholders to cast a non-binding advisory vote approving the Company’s executive pay program for its Named Executive Officers as described in the Compensation Discussion and Analysis and related tables. Management and the Human Resources and Compensation Committee (HRCC) argue the program strongly links pay to performance through a mix of base salary, an annual cash Annual Incentive Matrix (AIM) tied to Revenue, Adjusted EBITDA and Cash Flow with a Sustainability Modifier, and long-term incentives (stock options, RSUs and Performance Share Units) tied to CROIC and relative TSR. The Board highlights prior shareholder support (~90% in 2025) and emphasizes governance features such as significant performance-based pay, clawback policies, share ownership requirements, and use of an independent compensation consultant. A vote FOR would signal shareholder endorsement of the HRCC’s design choices, including sustainability integration into incentives and the specific mix and caps described. The vote is advisory and non-binding, but the Board commits to consider the outcome and engage with shareholders on feedback. Key risk considerations include potential shareholder concerns about pay levels, the scope of discretion retained by the HRCC for adjustments, and extensive use of equity and performance metrics that could deliver large payouts if targets are exceeded. The company's disclosure of prior outcomes, payout mechanics, and the +2% Sustainability Modifier for 2025 provides context for assessing the appropriateness of pay-for-performance alignment. Given the Board’s rationale and recent strong shareholder support, management recommends FOR, but shareholders should evaluate the detailed CD&A and pay tables to judge alignment with long-term value creation.

This management proposal seeks shareholder renewal of the Board’s authority under Irish law to allot up to approximately 20% of the Company’s issued ordinary share capital over an 18-month period. Management frames the request as routine and necessary to preserve corporate flexibility for equity compensation, funding acquisitions, and raising capital, while noting that it is not asking to increase authorized share capital but only to use existing authorized shares. The filing emphasizes that NYSE rules and SEC protections remain in place—e.g., shareholder approval is still generally required for issuances representing 20% or more of voting power or for change-of-control or related-party transactions—mitigating dilution risk. The resolution text specifies the aggregate nominal amount ($48,923,517) and incorporates customary provisos allowing allotments under offers made before expiration. Governance and investor concerns to consider include potential dilution from future issuances and how management will use the authority; however, the Board’s explicit commitment to market practices and prior similar approvals reduces the likelihood of opportunistic use. For investors, the key mitigants are the limited 20% cap, the 18‑month duration, and the Company’s disclosure of intended uses (employee compensation and potential acquisitions). The Board recommends FOR given the routine nature of the authorization and its role in enabling standard corporate financing and compensation activities in Ireland. Active shareholders may nonetheless monitor any large share issuances for timing and strategic justification.

This special management proposal requests shareholder approval under Irish law to disapply pre-emption rights so the Board may issue shares for cash without first offering them pro rata to existing shareholders, subject to limits and for an 18‑month period. The request is split into two parts: (a) preserve rights issues in favor of existing shareholders on a proportional basis (with customary exclusions), and (b) permit other cash issues up to ~20% of issued capital — mirroring the ordinary authority sought in Item 4 — allowing the Company to use shares for compensation plans, acquisitions and capital raising without procedural delay. Management frames this as routine market practice in Ireland and consistent with NYSE and U.S. standards; however, because it directly affects pre-emption protections, it requires a 75% majority under Irish law. The governance trade-off is between preserving management flexibility versus protecting existing shareholders from dilution and opportunistic issuances; the 20% cap, time limit and requirement for special resolution are key constraints. Active investors should weigh the Company’s capital allocation history, prior share issuance behavior, and stated likely uses (compensation and potential strategic transactions) when considering support. The Board’s recommendation FOR is supported by the need to maintain competitiveness with non-Irish NYSE-listed peers and ensure timely execution of transactions, but shareholders may seek additional safeguards (e.g., pre-commitment to limited issuance in RFPs or clearer disclosure on issuance purposes). Given the routine nature in the Irish market and the specified limits, the Board believes the authorization is appropriate and recommends approval.

This special resolution asks shareholders to approve the price parameters at which the Company may reallot treasury shares over the next 18 months, establishing a maximum of 120% and a minimum of either nominal value (for employee scheme obligations) or 95% of the market price for other reallotments, where market price is defined as the NYSE closing price on the day before reallotment. Management argues the authorization is procedural and required by Irish law to permit the Company to reissue treasury shares for compensation programs and other corporate needs at market-appropriate prices. From a governance perspective, the floor at 95% and the cap at 120% constrain potential opportunistic reallotments and preserve a degree of market fairness, while allowing the Company to price issuances competitively to meet strategic needs. Employee-plan related re-issues at nominal value are standard and intended to satisfy plan obligations that would otherwise be difficult to execute. The special resolution requires a 75% affirmative vote under Irish law, reflecting its significance. Shareholders should consider the Company’s recent buyback and treasury practices, the potential dilution impact of future reallotments, and whether the specified price band is consistent with shareholder interests. The Board recommends FOR given the routine nature of the request, the limited duration, and the policy that any reallotments will be made at prices the Board considers in shareholders’ best interests.